Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries

C C Butler, K Hood, T Verheij, P Little, H Melbye, J Nuttall, M J Kelly, S Mölstad, M Godycki-Cwirko, J Almirall, A Torres, D Gillespie, U Rautakorpi, S Coenen, H Goossens, C C Butler, K Hood, T Verheij, P Little, H Melbye, J Nuttall, M J Kelly, S Mölstad, M Godycki-Cwirko, J Almirall, A Torres, D Gillespie, U Rautakorpi, S Coenen, H Goossens

Abstract

Objective: To describe variation in antibiotic prescribing for acute cough in contrasting European settings and the impact on recovery.

Design: Cross sectional observational study with clinicians from 14 primary care research networks in 13 European countries who recorded symptoms on presentation and management. Patients followed up for 28 days with patient diaries.

Setting: Primary care.

Participants: Adults with a new or worsening cough or clinical presentation suggestive of lower respiratory tract infection.

Main outcome measures: Prescribing of antibiotics by clinicians and total symptom severity scores over time.

Results: 3402 patients were recruited (clinicians completed a case report form for 99% (3368) of participants and 80% (2714) returned a symptom diary). Mean symptom severity scores at presentation ranged from 19 (scale range 0 to 100) in networks based in Spain and Italy to 38 in the network based in Sweden. Antibiotic prescribing by networks ranged from 20% to nearly 90% (53% overall), with wide variation in classes of antibiotics prescribed. Amoxicillin was overall the most common antibiotic prescribed, but this ranged from 3% of antibiotics prescribed in the Norwegian network to 83% in the English network. While fluoroquinolones were not prescribed at all in three networks, they were prescribed for 18% in the Milan network. After adjustment for clinical presentation and demographics, considerable differences remained in antibiotic prescribing, ranging from Norway (odds ratio 0.18, 95% confidence interval 0.11 to 0.30) to Slovakia (11.2, 6.20 to 20.27) compared with the overall mean (proportion prescribed: 0.53). The rate of recovery was similar for patients who were and were not prescribed antibiotics (coefficient -0.01, P<0.01) once clinical presentation was taken into account.

Conclusions: Variation in clinical presentation does not explain the considerable variation in antibiotic prescribing for acute cough in Europe. Variation in antibiotic prescribing is not associated with clinically important differences in recovery.

Trial registration: Clinicaltrials.gov NCT00353951.

Conflict of interest statement

Competing interests: None declared.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787328/bin/butc607135.f1_default.jpg
Fig 1 Patient flow chart
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787328/bin/butc607135.f2_default.jpg
Fig 2 Choice of antibiotic by network
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787328/bin/butc607135.f3_default.jpg
Fig 3 Unadjusted and adjusted odds ratios for antibiotic prescribing by network (both adjusted for clustering within clinician). All networks are compared with overall mean
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787328/bin/butc607135.f4_default.jpg
Fig 4 Unadjusted median symptom severity scores over time by network
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4787328/bin/butc607135.f5_default.jpg
Fig 5 Predicted recovery curves by network for those prescribed antibiotics from ARMA model

References

    1. Grundmann H. EARSS annual report 2007. Bilthoven, Netherlands: European Antimicrobial Resistance Surveillance System, 2007:40.
    1. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
    1. Macfarlane J, Lewis SA, Macfarlane R, Holmes W. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the UK: implications for developing management guidelines. Respir Med 1997;91:427-34.
    1. Akkerman AE, Kuyvenhoven MM, van der Wouden JC, Verheij TJM. Prescribing antibiotics for respiratory tract infections by GPs: management and prescriber characteristics. Br J Gen Pract 2005;55:114-8.
    1. Smucny J, Fahey T, Becker L, Glazier R, McIsaac W. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2000;(4):CD000245.
    1. Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001;56:109-14.
    1. Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner G, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA 2005;293:3029-35.
    1. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London: Arnold, 2000.
    1. Goldstein H. Multilevel statistical models. London: Hodder Arnold, 2003.
    1. Box GEP, Jenkins GM. Time series analysis: forecasting and control. Rev ed. San Francisco: Holden-Day, 1976.
    1. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2007.
    1. Bates D. lme4: Linear mixed-effects models using S4 classes. 2007; R package version 0.99875-8.
    1. Pinheiro J, Bates D, DebRoy S, Sarkar D, The R Core team. nlme: Linear and Nonlinear Mixed Effects Models. 2007; R package version 3.1-83.
    1. Akkerman AE, Kuyvenhoven MM, Verheij TJM, van Dijk L. Antibiotics in Dutch general practice: nationwide electronic GP database and national reimbursement rates. Pharmacoepidemiol Drug Saf 2008;17:378-83.
    1. Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J 1996;9:1590-5.
    1. Bjerrum L, Boada A, Cots J, Llor C, Fores Garcia D, et al. Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain. Eur J Clin Pharmacol 2004;60:23-8.
    1. Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz H-H. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster-randomized intervention study. J Antimicrob Chemother 2007;60:638-44.
    1. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005;(4):CD003539.
    1. Coenen S, Van Royen P, Michiels B, Denekens J. Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial. J Antimicrob Chemother 2004;54:661-72.
    1. Welschen I, Kuyvenhoven MM, Hoes AW, Verheij TJ. Effectiveness of a multiple intervention to reduce antibiotic prescribing for respiratory tract symptoms in primary care: randomised controlled trial. BMJ 2004;329:431.
    1. Cals JWL, Butler CB, Hopstaken RM, Hood K, Dinant G. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ 2009;338;b1374.
    1. Butler CC, Dunstan F, Heginbothom M, Mason B, Roberts Z, Hillier S, et al. Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices. Br J Gen Pract 2007;57:785-92.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren